PDL BioPharma (PDLI) Shares Cross Below 200 DMA

In trading on Wednesday, shares of PDL BioPharma Inc ( PDLI) crossed below their 200 day moving average of $7.32, changing hands as low as $7.31 per share. PDL BioPharma Inc shares are currently trading down about 1.5% on the day. The chart below shows the one year performance of PDLI shares, versus its 200 day moving average:

START SLIDESHOW:
Click here to find out which 9 other stocks recently crossed below their 200 day moving average »

PDL BioPharma Inc 200 Day Moving Average Chart

Looking at the chart above, PDLI's low point in its 52 week range is $6.09 per share, with $8.43 as the 52 week high point — that compares with a last trade of $7.33.

According to the ETF Finder at ETF Channel, PDLI makes up 2.64% of the Dynamic Biotechnology & Genome Portfolio ETF ( PBE) which is trading lower by about 1.7% on the day Wednesday.
null

If you liked this article you might like

Sarepta Pops on Bullish Sentiment Around Duchenne Therapy, PDL Up on Merck Deal: Biotech Movers

Argos Plummets 72%, Leads Biotech Movers

Eli Lilly's Alzheimer's Drug Study Results Are Coming -- Here's What Investors Need to Know

PDL BioPharma (PDLI) Stock Plummets on Q2 Revenue Miss

Today's Weak On High Volume Stock: PDL BioPharma (PDLI)